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In patients with chronic kidney disease (CKD) and heart failure (HF), volume
overload is a major problem. Removal of fluid during the dialysis treatment is the
cornerstone management in these conditions, but assessing the amount of volume
that should be removed is a challenge since physical exam findings are not
accurate. Ambulatory pulmonary artery (PA) pressure measurement is a promising
tool in HF that potentially could be used as well in CKD population, monitoring
volume status changes and allowing a prompt intervention such as increasing or
decreasing the volume of ultrafiltration. We presented two cases of patients with
CKD, HF and CardioMEMS.
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Introduction
Chronic kidney disease (CKD) affects 13.6 % of the US population1. A significant
proportion of these patients progresses to end stage renal disease (ESRD)
requiring renal replacement therapy or renal transplantation. Cardiovascular
disease remains the most common cause of mortality in these patients2.
Volume overload is a major problem in patients with kidney failure especially in
those with an underlying heart disease3. It is not uncommon for dialysis patients to
develop signs and symptoms of volume overload. Hence, removal of fluid during
the dialysis treatment, also known as ultrafiltration, is the cornerstone of volume
management in advanced-stage CKD4.
Previous studies have revealed that excessive inter-dialytic weight gain is
associated with adverse clinical outcomes5–9, finding it to be an independent
predictor of all-cause and cardiovascular mortality in dialysis patients5. In addition,
accumulating evidence shows that inter-dialytic weight gain is significantly
associated with left ventricular hypertrophy and risk of cardiovascular mortality10,11.
It could be helpful to prevent excessive inter-dialytic weight gain for improving
clinical outcomes in incident dialysis patients12.
A main challenge related to ultrafiltration is the assessment of the volume status
and the required intra-dialytic fluid removal. Target weight in dialysis patients is the
most commonly used method, and it is defined as the lowest tolerable body weight
not associated with symptoms of hypovolemia13,14. However, in many
circumstances it might be impossible to determine the ideal target weight based on
clinical findings. Furthermore, this routine assessment has not contributed to
reducing cardiovascular mortality in dialysis patients, which is ultimately one of the
main long-term goals of renal replacement therapy.
CardioMEMS system (Abbott, Abbott Park, IL) is a pressure sensor implanted into
the pulmonary artery (PA) for remote monitoring of PA pressure in ambulatory
patients. Pulmonary arterial pressure-guided heart failure (HF) management using
CardioMEMS was tested in the CHAMPION trial (CardioMEMS Heart Sensor
Allows Monitoring of Pressure to Improve Outcomes in NYHA (New York Heart
Association) functional Class III Heart Failure Patients) and resulted in substantial
reductions of hospitalizations for HF15. Testing of CardioMEMS in dialysis patients
with HF seems logical, promising and has the potential of optimizing volume status
and reducing cardiovascular complications.
Herein we are reporting on two HF patients who had CardioMEMS and were later
started on dialysis. Interestingly, one of them was switched from hemodialysis to
peritoneal dialysis.

Methods
We retrospectively reviewed medical records of the two patients and collected the
data on their demographics, clinical condition, medications, results of right heart
catheterization, and echocardiographic reports. Also, we extracted the following
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data from the hemodialysis records: pre-and post-dialytic weight, systemic blood
pressure and heart rate, and the volume of fluid removed per session.
We then collected CardioMEMS’s data, including PA systolic, diastolic, and mean
pressure. Subsequent information on 60 CardioMEMS readings before the
beginning of hemodialysis and equal number of readings on hemodialysis were
collected. On the patient who was later switched to peritoneal dialysis, the
readings of CardioMEMS while she was on peritoneal dialysis were collected as
well. Mean PA pressures before and after the beginning of hemodialysis and on
peritoneal dialysis were compared for each patient using Student’s t-test.

Case 1. Heart Failure with Preserved Ejection Fraction
65-year-old Caucasian female with history of type II diabetes, hypertension, CKD,
hypothyroidism, hepatitis C, liver cirrhosis, had NYHA class III diastolic HF.
Echocardiogram showed left ventricular ejection fraction >55%, normal right
ventricular systolic function, right ventricular systolic pressure 40-50 mmHg,
normal atrial and ventricular size (left ventricular end diastolic dimension 4.1 cm)
and no valvular abnormalities. Cardiac catheterization demonstrated the following
pressures: right atrium 11 mmHg, right ventricle 50/11 mmHg, PA 50/16 mmHg
(mean 30 mmHg), pulmonary capillary wedge pressure 30 mmHg, cardiac output
7.0 L/min and cardiac index 3.6 L/min/m2. CardioMEMS was implanted in
November 2016. Her medications included metolazone 10 mg once a day,
bumetanide 2mg twice a day, carvedilol 12.5 mg twice a day, isosorbide
mononitrate 60 mg once a day, hydralazine 100 mg three times a day, cinacalcet
30 mg once a day, insulin and levothyroxine.
Patient had declining kidney function, and intermittent hemodialysis (HD) was
initiated via a tunneled catheter in September 2018. Patient received 3.5 hour HD
sessions regularly 3 times a week with an average blood flow rate of 400
ml/minute and a fluid removal of 2 liters aiming a target weight of 78 kg.
Patient’s vital signs and laboratory values are listed in Table 1. There was no any
need to early terminate dialysis for hemodynamic instability or arrhythmias but she
had complained of bad cramps with any attempt of taking take more fluid off.
Table 1. Patient 1: Clinical parameters before and after dialysis session
Before HD session

After HD session

P

Mean ± SD

Mean ± SD

Weight, kg

78.2 ± 0.8

76.8 ± 0.6

<0.0001

Systolic BP, mmHg

159.2 ± 30.2

149.1 ± 27.5

0.2

Diastolic BP, mmHg

68.6 ± 11.5

64.5 ± 14.7

0.3

Heart rate, beats per minute

60.2 ± 8.2

57.7 ± 4.7

0.2

Net volume removed, L

1.45 ± 0.7

BP- blood pressure
HD – hemodialysis
SD – standard deviation
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Her dialysis adequacy measures were optimal (an average KT/V of 1.5, where K is
the dialyzer clearance of urea, T stands for dialysis time and V is the volume of
distribution of urea).
The patient was switched to continuous cyclic peritoneal dialysis (PD) through a
Tenckhoff PD catheter in January 2019 using four cycles with a total dialysate
volume of 8800 ml over 8.5 hours. Her average KT/V was 2.0. Her PA pressure by
CardioMEMS increased after initiation of the HD but decreased after PD was
established (Figure 1, Table 2).
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Case 2. Heart Failure with Reduced Ejection Fraction
73-year-old Caucasian male with history of type II diabetes, hypertension, and
CKD had NYHA class III systolic HF secondary to ischemic cardiomyopathy.
Echocardiogram showed decreased left ventricular ejection fraction <25%, with a
dilated left ventricle (end diastolic dimension of 6.4 cm), right ventricular systolic
pressure 94 mmHg, and moderate mitral regurgitation. Right side heart
catheterization demonstrated the following pressures: right atrium 11 mmHg, right
ventricle 61/13 mmHg, PA 67/26 mmHg (mean 43 mmHg), pulmonary capillary
wedge pressure 46 mmHg, cardiac output 5.7 L/min and cardiac index 2.8
L/min/m2. CardioMEMS was implanted in October 2016.
Patient had declining kidney function. A right upper arm arteriovenous fistula was
placed, and intermittent HD was initiated in July 2018. Patient received 4 hours HD
session regularly 3 times a week with an average blood flow rate of 400 ml/min
and a fluid removal of 3.5-4.5 liters aiming a target weight of 89 kg (Table 3).
There was no need to early terminate any of the dialysis sessions for
hemodynamic instability or arrhythmia.

His dialysis adequacy measures were optimal (an average KT/V of 1.7) His
medications included carvedilol 25mg twice a day, hydralazine 100 mg three times
a day, Insulin and glimepiride. His PA pressures readings by CardioMEMS
gradually declined after initiation of dialysis (Figure 2, Table 4).
The volume of fluid removed per HD session was significantly greater in the
second patient (3.2 ± 1.2 L vs 1.45 ± 0.7 L, P <0.0001). When we indexed the net
volume removed for pre-dialysis weight, the difference persisted (0.003 ± 0.013 vs
0.019 ± 0.009, P <0.0001).
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Discussion
Heart failure is a chronic condition, with the symptoms resulting from fluid retention
due to inadequate cardiac output and elevated cardiac filling pressures3. Chronic
volume overload in both HF and CKD results in left ventricular hypertrophy,
dilatation and cardiac dysfunction, with or without decrease in left ventricular
ejection fraction, increasing the risk of cardiovascular mortality16. Reversing
hypervolemia remains the key management strategy in renal disease patients with
HF3. In cases where hypervolemia is not controlled, dialysis could be used as an
alternative. A previous prospective randomized study compared ultrafiltration and
intravenous diuretics in patients hospitalized for acute decompensated HF and
reported more fluid removal and decreased rehospitalization rates in those
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undergoing ultrafiltration18. These results could be extrapolated to show the
potential value of extracorporeal ultrafiltration as a treatment for HF in long-term
dialysis patients.
The CHAMPION Trial demonstrated the utility of PA pressure
guided HF management strategy using a wireless implantable
hemodynamic monitoring system. Patients managed with the addition to
ambulatory hemodynamic monitoring were compared with patients on HF
management based on practice guidelines only. CardioMEMS’ patients showed
substantial reductions in hospital admissions for HF, irrespective of left ventricular
pump function. This is probably because the PA pressure guided HF management
facilitates timely recognition of incipient hypervolemia and appropriate modification
of medical treatment.15
We described two cases of patient with advanced CKD, HF and cardioMEMS,
patients were identified to have elevated PA pressures even after receiving HD. A
main challenge related to ultrafiltration in dialysis patients is the assessment of the
required magnitude and frequency of fluid removal5. Dry weight is one of the most
common methods used, but given that clinical findings are imprecise, this method
cannot accurately predict the ultrafiltration volume12. Not uncommonly patients
develop manifestations of hypovolemia during and after dialysis. It is well
established that excessive volume removal is associated with repeated episodes
of myocardial stunning developing regional fixed left ventricular dysfunction and
worsening HF19. On the other hand, insufficient fluid removal is also associated
with volume overload, deteriorating HF and worsening pulmonary hypertension.
Another challenging situation is choosing the dialysis modality. The notion is
continuos dialysis therapies are more hemodynamically tolerable and associated
with less myocardial stunning. This is probably because of gentle fluid removal20,
21
.
In our case number 1, the patient PA pressures, already elevated, worsened while
on HD but significantly improved after she was switched to PD. In the two cases
we presented, starting of dialysis clearly resulted in change of their PA pressures.
In the first case of HF with preserved ejection fraction and small left ventricle,
pulmonary pressures significantly increased. In the second case of HF with
reduced ejection fraction and enlarged left ventricle, PA pressures decreased.
In non-dialysis patients with HF, volume status is primarily controlled with loop
diuretics, and the effect is dose-dependent. In HD, fixed volume of fluid is
removed three times a week. In the first patient, the amount of fluid removal could
not be increased on HD because she experienced symptoms of hypovolemia. In
HF with preserved ejection fraction small changes in intravascular volume produce
marked changes in intra-cardiac pressures22, possibly due to small and noncompliant left ventricle.
On the other hand, the patient with large ventricle tolerated higher volumes of fluid
removed per HD session. The amount of fluid removal per HD session was lower
in the first compared to the second patient, both in absolute values and indexed for
body weight. The first patient’s hemodynamics much improved on PD with more
gentle and gradual fluid removal. This might be because PD allows more time for
the heart to accommodate intravascular volume changes as it is more slow/chronic
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dialysis therapy compared to HD. Of note, hemodynamic response to dialysis in
these two patients demonstrates that approach to chronic renal replacement
therapy may differ in patients with HF with reduced and preserved ejection
fraction.

Conclusions
Management of fluid status is a significant challenge in dialysis patients with HF.
Up to date there is no clear recommendation of how to determine the appropriate
amount of ultrafiltration. Remote ambulatory monitoring of PA pressures helps in
guiding the amount of fluid removal in this patient population. Testing
CardioMEMS in this clinical setting is promising since it accurately predicts the
volume status. Ambulatory monitoring of volume status may help with decision
making on the modality of dialysis. More studies are needed in order to establish
the utility of using this device in improving clinical outcome.
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